Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Administrative Information

Administrative Information

Miscellaneous administrative trivia such as site policies and other mandated information.
Disclaimer of Endorsement and Liability
Official policies of the Early Detection Research Network.
Viewing Files
In addition to standard HTML Web pages, our web site contain other file formats. You may need additional software or browser plug-ins to view some of the information available on our site. This document lists show each format, along with links to the corresponding freely available plug-ins or viewers.
Images
Images used in administrative documents.
Freedom of Information Act
Information about the Freedom of Information Act and how it pertains to the Early Detection Research Network.
File GA Limited Cookies
Modification to Google Analytics courtesy of Debra Beckham (NCI Web) that limits the lifetime of the Google Analytics cookies.
Viewing Tables
Tabular information may be sorted by clicking on column headings.
New Funding Opportunity: Biomarker Development Laboratories for the Early Detection Network: Applications Due May 23

Update: Pre-application webinar information now available.

The National Cancer Institute's Division of Cancer Prevention has released a new funding opportunity to solicit organ-specific applications for Biomarker Developmental Laboratories (BDLs), one of the four scientific units of the recently funded Early Detection Research Network (EDRN). The EDRN is a national infrastructure funded to discover, develop, and validate biomarkers for risk assessment, detection, and molecular diagnosis and prognosis of early cancer. BDLs are responsible for the discovery, development, characterization, and testing of new, or the refinement of existing, biomarkers and biomarker assays for risk assessment, detection, and molecular diagnosis and prognosis of cancers.

The existing BDLs are primarily focused on ovary and gastrointestinal cancers. The proposed BDLs (to be supported under this funding opportunity) should be focused on one or more of the following cancers: breast, prostate and other genitourinary organs, or lung. In addition, cancers with rapidly rising incidence rates, e.g., endometrial, hepatocellular, kidney, thyroid, oropharyngeal cancers, and/or cancers with unique etiology, e.g., mesothelioma, will be considered.

The newly funded units of the Early Detection Research Network will be announced later in April. Successful applicants have already been notified. Those researchers who were not successful during the last round of applications are encouraged to apply to this opportunity.